Novel alpha O-conotoxin peptide GeXIVA new mutant as well as pharmaceutical composition and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- HAINAN UNIVERSITY
- Publication Date
- 2020-12-01
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the fields of pharmacy, biochemistry, molecular biology and neuroscience, and relates to αO-conotoxin peptide GeXIVA and a series of new mutants thereof, its pharmaceutical composition, its preparation method and its application. The present invention also relates to a method for blocking nicotinic acetylcholine receptors (nAChRs), and the pharmaceutical use of the conotoxin peptide. Background technique
[0002] A variety of polypeptide toxins produced in the venom of carnivorous molluscs living in tropical oceans are called conotoxins or conopeptides. Conotoxins have the special function of specifically binding to various ion channels and receptors in animals [1] , has leapt to the first place in the study of animal toxins, and is known as the "treasure house of marine drugs" and "the untapped treasury". Conotoxins have become a hot spot in neuroscience research and new drug development.
[0003] Conotoxins have diverse th...